Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Viral load and HIV-associated nephropathy

Hassane Izzedine, Marc Wirden, Vincent Launay-Vacher

    The New England Journal of Medicine
    |September 9, 2005
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clearance of NNRTI resistance-associated mutations in the HIV-1 DNA reservoir with or without the presence of M184V mutation.

    The Journal of antimicrobial chemotherapy·2026
    Same author

    Add-on efficacy of doravirine in PLWHIV with virological failure and low-level viremia.

    The Journal of antimicrobial chemotherapy·2026
    Same author

    A French national observatory of people with HIV initiating lenacapavir-based treatment after regulatory approval.

    Antimicrobial agents and chemotherapy·2026
    Same author

    HBV reactivation after switching to cabotegravir plus rilpivirine therapy among people living with HIV: do not forget the reservoir.

    The Journal of antimicrobial chemotherapy·2026
    Same author

    First characterization of insertions in the HIV-1 integrase-coding region from people with HIV.

    The Journal of antimicrobial chemotherapy·2026
    Same author

    Antiretroviral resistance in at least second-line HIV-1 treatment virologic failure with common InSTI-based regimens.

    AIDS (London, England)·2025